ADSERVO LTD

Company number 15892247 · Active

ADSERVO LTD is a private limited company registered in MILDENHALL, United Kingdom, incorporated on 12 Aug 2024. Its registered activity is general medical practice activities. Its latest published accounts for the period ending 31 Aug 2025 show equity of £2,364, total assets of £4,714. It has filed 1 set of accounts.

Company details

Company number
15892247 · official register
Status
Active
Legal form
Private Limited Company
Incorporated
12 Aug 2024 (2 years)
Registered address
IP28 7DE MILDENHALL
Postcode area
Ipswich
Activity
86210 General medical practice activities
Industry
Human health activities
Accounts overdue
No

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
31 Aug 202515 Apr 2026– –£2,364£4,714 £2,351–0

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in Ipswich

Questions about ADSERVO LTD

What is the company number of ADSERVO LTD?

ADSERVO LTD is registered under company number 15892247 in the official register of United Kingdom. View it at the official register.

Is ADSERVO LTD still active?

Yes. ADSERVO LTD is registered as active (status: Active).

Has ADSERVO LTD gone bankrupt or into insolvency?

No insolvency, bankruptcy or administration is recorded for ADSERVO LTD in the official data.

When was ADSERVO LTD founded?

ADSERVO LTD was incorporated on 12 Aug 2024.

Where is ADSERVO LTD registered?

ADSERVO LTD's registered address is in IP28 7DE MILDENHALL (Ipswich), United Kingdom.

What do the latest accounts of ADSERVO LTD show?

The latest published accounts (period ending 31 Aug 2025) show equity of £2,364, total assets of £4,714, 0 employees.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 7 Nov 2026.